Form D · Other

Predictive Oncology Inc.

Pittsburgh, PA · CIK 0001446159

Offering snapshot reported Oct 22, 2025 · SEC filing

Reported sold
$173M
Offering amount: $173M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 7, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 22, 2025Initial$173,274,405No comparison20SEC filing
Oct 22, 2025Initial$50,769,628No comparison29SEC filing
Sep 8, 2025Initial$413,093No comparison1SEC filing
Aug 2, 2024Initial$2,161,032No comparison8SEC filing
Jun 2, 2022Amendment$2,302,368$0vs Jun 2, 20224SEC filing
Jun 2, 2022Initial$2,302,368No comparison4SEC filing
Mar 18, 2021Amendment$16,760,975$7,389,004vs Feb 2, 202110SEC filing
Mar 18, 2021Initial$17,635,343No comparison19SEC filing
Feb 2, 2021Initial$9,371,971No comparison10SEC filing
Jul 10, 2020Initial$1,750,000No comparison18SEC filing
Mar 30, 2020Initial$3,500,000No comparison2SEC filing
Jul 29, 2019Initial$1,139,000No comparison11SEC filing
Oct 11, 2018Initial$2,000,000No comparison2SEC filing
Dec 12, 2017Initial$1,300,000No comparison1SEC filing
Aug 6, 2014Initial$122,196No comparison1SEC filing
Jul 24, 2014Initial$733,174No comparison2SEC filing
Feb 5, 2014Initial$2,055,000No comparison16SEC filing
Jun 20, 2013Amendment$1,000,000$450,000vs Jun 3, 201313SEC filing
Jun 3, 2013Initial$550,000No comparison4SEC filing
Mar 25, 2013Initial$500,000No comparison1SEC filing
Feb 11, 2013Initial$154,000No comparison3SEC filing
Jan 10, 2013Initial$275,000No comparison3SEC filing
Dec 4, 2012Amendment$623,447$468,457vs Jun 29, 201225SEC filing
Jun 29, 2012Initial$154,990No comparison7SEC filing
Nov 4, 2009Initial$1,593,502No comparison32SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-561735

Source: Form D, filed Oct 22, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Raymond F. Bennare Director, Executive
Josh Blacher Executive
Nancy Chung Welch Director
James E. Dauwalter Director
Kevin R. Davidson Director, Executive
Kirsten Doerfert Executive
Arnon Dreyfuss Director
J Melville Engle Director, Executive
Richard L Gabriel Director
Lawrence W. Gadbaw Director, Executive
Jeffrey Galitz Director
Dan Hadley Director
Daniel E Handley Director
Matthew Hawryluk Director
Christina Jenkins Director
David Johnson Executive
Ricardo Koenigsberger Director
Joshua Kornberg Director, Executive
Timothy A Krochuk Director
Frank Mancuso Director
Shawn Matthews Director
Thomas Mc Goldrick Director
Thomas L. Mc Laughlin Executive
Peter L. Morawetz Director
Bob Myers Executive
Robert Myers Executive
Chuck Nuzum Director
Pam S Prior Director
Veena Rao Director
Andrew P Reding Director
Chad A. Ruwe Director
Carl I Schwartz Director, Executive
Alan Shuler Executive
Gregory St. Clair Director
Gregory S St. Clair Sr. Director
Gregory S. St. Clair, Sr. Director
Gerald J Vardzel Director
Raymond F. Vennare Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
91 43 Rd Street Suite 110
Pittsburgh, PA, 15201